LEVOCARNITINE: Pharmaceutical manufacturers, suppliers, and packagers

Subscribe to access the full database, or Get Started Free
Applicant	Tradename	Generic Name	Dosage	NDA	NDA/ANDA	Supplier	Package Code	Package	Marketing Start
Leadiant Biosci Inc	CARNITOR	levocarnitine	INJECTABLE;INJECTION	020182	NDA	Leadiant Biosciences, Inc.	54482-147-01	5 VIAL in 1 CARTON (54482-147-01) / 5 mL in 1 VIAL	1992-12-16
Am Regent	LEVOCARNITINE	levocarnitine	INJECTABLE;INJECTION	075861	ANDA	American Regent, Inc.	0517-1045-05	5 VIAL, SINGLE-DOSE in 1 CARTON (0517-1045-05) / 5 mL in 1 VIAL, SINGLE-DOSE (0517-1045-01)	2023-06-21
Am Regent	LEVOCARNITINE	levocarnitine	INJECTABLE;INJECTION	075861	ANDA	American Regent, Inc.	0517-1075-01	1 VIAL, SINGLE-DOSE in 1 CARTON (0517-1075-01) / 20 mL in 1 VIAL, SINGLE-DOSE	2023-06-21
Deva Holding As	LEVOCARNITINE	levocarnitine	INJECTABLE;INJECTION	217430	ANDA	Devatis Inc.	73043-034-05	5 VIAL in 1 CARTON (73043-034-05) / 5 mL in 1 VIAL	2025-11-01
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>NDA/ANDA	>Supplier	>Package Code	>Package	>Marketing Start

Last updated: July 27, 2025

Introduction

Levocarnitine, also known as L-carnitine, is a vital compound used in clinical settings to treat carnitine deficiency and associated metabolic disorders. As a widely prescribed supplement and pharmaceutical agent, its supply chain comprises numerous global manufacturers, bulk suppliers, and distributors. Ensuring reliable access to high-quality levocarnitine is crucial for healthcare providers, pharmaceutical companies, and regulatory agencies. This article offers a comprehensive analysis of key suppliers, highlighting recent market trends, major manufacturers, and strategic considerations for supply chain resilience.

Overview of Levocarnitine Chemistry and Uses

Levocarnitine is a naturally occurring quaternary ammonium compound involved in fatty acid transport within mitochondria, playing a critical role in energy production. It is administrated orally, intravenously, or via other parenteral routes, mainly for treating primary and secondary carnitine deficiencies, metabolic disorders, and certain cardiac and neurological conditions (Source: [1]).

Given its therapeutic importance, the demand for pharmaceutical-grade levocarnitine continues to grow, prompting an expanding supply base—ranging from raw material producers to final drug manufacturers.

Major Raw Material Suppliers

1. Global Raw Material Producers

Levocarnitine production predominantly hinges on specialized chemical manufacturers capable of synthesizing high-purity intermediates. Key raw materials include amino acids, methylating agents, and other chemicals involved in synthetic pathways.

Notable raw material suppliers include:

BASF: A leading supplier of specialty chemicals, BASF produces chemical precursors used in levocarnitine synthesis, such as amino acid-based intermediates. Their global supply network ensures broad availability for pharmaceutical manufacturing.
Shandong Sinobioway Biotech Co., Ltd.: Based in China, this company supplies raw materials and intermediates for amino acid derivatives, including precursors used in levocarnitine synthesis.
Jiangsu Hengrui Medicine Co., Ltd.: Specializes in producing pharmacologically active compounds and intermediates, providing raw materials crucial in levocarnitine production.

The raw material supply chain is subject to regional regulatory standards, quality controls, and geopolitical factors affecting procurement.

Manufacturers of Pharmaceutical-Grade Levocarnitine

2. Key Global Manufacturers

The production of pharmaceutical-grade levocarnitine involves complex synthesis processes, stringent quality controls, and compliance with international pharmacopeias such as USP, EP, and JP.

Major pharmaceutical levocarnitine suppliers include:

Meiji Seika Kaisha, Ltd. (Japan): One of the oldest and most reputable suppliers, Meiji offers high-purity levocarnitine in injectable and oral forms, widely used in clinical settings across Asia, North America, and Europe.
Fenex Pharmaceuticals (India): Known for producing extensive pharmaceutical excipients and active ingredients, Fenex supplies high-quality levocarnitine, leveraging cost competitiveness and robust manufacturing standards.
Zhejiang Youbang Pharmaceutical Co., Ltd. (China): A prominent domestic producer that has expanded globally, providing both raw levocarnitine and finished formulations.
Shenzhen Behemoth Pharmaceutical Co., Ltd. (China): Specializes in amino acid derivatives and levocarnitine formulations, catering to global markets.
Jubilant Ingrevia (India): A leading provider of amino acids and derivatives, Jubilant Ingrevia produces pharmaceutical grade levocarnitine with a focus on quality consistency.

3. Manufacturing Processes and Quality Standards

Levocarnitine synthesis typically involves proprietary chemical pathways, with some manufacturers employing biotechnological fermentation methods. These processes ensure the high purity required for intravenous and oral medicines.

Strict adherence to Good Manufacturing Practices (GMP), along with certifications such as ISO 9001, ensures product safety and regulatory compliance. Notably, the chemical purity, bioavailability, and stability of levocarnitine are critical parameters that distinguish suppliers.

Market Dynamics and Supply Trends

The global levocarnitine market is influenced by several factors, including:

Increasing clinical applications: The rising prevalence of metabolic disorders and the demand for nutritional supplements fuel market growth.
Supply chain diversification: Geopolitical tensions and disruptions have led companies to diversify sourcing, engaging multiple suppliers across Asia, Europe, and North America.
Vertical integration: Major pharmaceutical companies increasingly integrate raw material sourcing with finished product manufacturing, reducing dependency and enhancing supply security.

Accordingly, the market is characterized by competition among raw material suppliers and finished product manufacturers, with emerging players investing in process innovation to lower costs and improve quality.

Regional Supply and Regulatory Considerations

Asia-Pacific: Home to most pharmaceutical-grade levocarnitine producers, notably China and India, offering cost-competitive products but facing regulatory scrutiny regarding quality standards and transparency.
Europe & North America: Preferred regions for high-quality levocarnitine, often linked to stricter regulatory regimes (EMA, FDA). Major European companies tend to dominate supply to these markets.
Regulatory Compliance: Suppliers must meet Good Manufacturing Practice (GMP), along with certifications like ISO 13485 for medical devices or pharmaceutical-specific standards, to ensure market acceptance.

Strategic Sourcing and Supply Chain Resilience

Given the critical role of levocarnitine in healthcare, supply chain resilience hinges on diversification of suppliers, adherence to quality standards, and proactive inventory management. Companies are also investing in process optimization, such as green synthesis pathways, to ensure sustainable and cost-effective production.

Importantly, recent trends indicate an increasing shift toward biotechnological synthesis methods, reducing reliance on traditional chemical routes, which could impact future supplier landscapes.

Key Takeaways

The global supply of pharmaceutical levocarnitine is dominated by manufacturers in Asia—particularly China and India—supplying both raw materials and finished products.
High-quality, GMP-compliant suppliers such as Meiji Seika and Jubilant Ingrevia ensure regulatory adherence and product safety in Western markets.
Diversification and robust quality assurance are essential strategies for mitigating supply disruptions, especially amid geopolitical and logistical uncertainties.
Emerging biotechnology approaches promise to transform the supply landscape by enabling more sustainable and cost-effective production.
For healthcare and pharmaceutical companies, establishing strategic partnerships with multiple reputable suppliers enhances supply security and compliance.

FAQs

Q1: What are the key certifications to look for in levocarnitine suppliers?
Answer: Suppliers should hold GMP certification and relevant pharmacopeia standards (USP, EP, JP). Certifications like ISO 9001 and ISO 13485 further ensure quality management and compliance.

Q2: Are there regional differences in the quality of levocarnitine?
Answer: Yes. While Asian manufacturers offer cost-competitive products, Western markets often prefer suppliers with stringent regulatory compliance and higher purity standards. Regulatory clearance processes differ by jurisdiction.

Q3: How has the COVID-19 pandemic affected levocarnitine supply chains?
Answer: Pandemic-related disruptions, including factory shutdowns and logistical delays, have underscored the importance of diversified sourcing and inventory buffers to prevent shortages.

Q4: What role does biotechnology play in levocarnitine production?
Answer: Emerging biotechnological methods involve fermentation processes that may offer higher purity, lower environmental impact, and potentially lower costs compared to traditional chemical synthesis.

Q5: How can pharmaceutical companies ensure the sustainability of their levocarnitine supply?
Answer: Companies should establish multi-source relationships, conduct thorough supplier audits, monitor regulatory compliance, and invest in inventory management to mitigate risks.

References

[1] "Levocarnitine: Uses, Side Effects, and Precautions." Mayo Clinic.

[2] "Pharmaceutical Grade Levocarnitine Market: Industry Analysis and Forecast." Market Research Future.

[3] "Critical Process Attributes and Validation Protocols for Levocarnitine Manufacturing." International Journal of Pharmaceutical Sciences.

[4] "Global Amino Acid Derivates Market," Transparency Market Research, 2022.

[5] "Carrier-Free Synthesis of Levocarnitine," Journal of Organic Chemistry, 2021.

Suppliers and packagers for generic pharmaceutical drug: LEVOCARNITINE

LEVOCARNITINE

Suppliers for the Pharmaceutical Drug: Levocarnitine